PMPCA-Related Encephalopathy: Novel Variants, Phenotype Extension, and Mitochondrial Morphology

IF 3 3区 医学 Q2 CLINICAL NEUROLOGY
Vibhuti Rambani, Miriam Kolnikova, Michal Cagalinec, Martina Skopkova, Daniela Gasperikova
{"title":"PMPCA-Related Encephalopathy: Novel Variants, Phenotype Extension, and Mitochondrial Morphology","authors":"Vibhuti Rambani, Miriam Kolnikova, Michal Cagalinec, Martina Skopkova, Daniela Gasperikova","doi":"10.1212/nxg.0000000000200106","DOIUrl":null,"url":null,"abstract":"<sec><st>Objectives</st>\n<p>The <I>PMPCA</I> gene encodes the &alpha;-subunit of mitochondrial processing peptidase (&alpha;-MPP), an enzyme responsible for cleavage of nuclear-encoded mitochondrial precursor proteins after their import into mitochondria. Mutations in this gene have been described in patients with nonprogressive or slow progressive cerebellar ataxia, with variable age at onset and severity. Cerebellar atrophy and striatum changes were found in severe cases.</p>\n</sec>\n<sec><st>Methods</st>\n<p>The patient was diagnosed using whole exome sequencing. Skin fibroblasts were used for confirmation of &alpha;-MPP levels using western blot and mitochondrial morphology assessment of immunofluorescent confocal microscopy images.</p>\n</sec>\n<sec><st>Results</st>\n<p>Two novel compound heterozygous variants in the <I>PMPCA</I> gene (p.Tyr241Ser and p.Met251Val) were identified in an 8-year-old proband with progressive spastic quadriparesis, delayed psychomotor development, and intellectual disability, with onset at 13 months. The brain imaging showed cortical and cerebellar atrophy, reduced volume of basal ganglia with striatum hyperintensity, and periventricular white matter changes. The patient's fibroblasts showed a decreased &alpha;-MPP level and reduced and fragmented mitochondria.</p>\n</sec>\n<sec><st>Discussion</st>\n<p>The described case contributes to the number of patients with progressive <I>PMPCA</I>-related disease with a severe intermediate phenotype. Moreover, we extend the phenotype to Leigh-like white matter changes that have not been described in previously reported cases.</p>\n</sec>","PeriodicalId":48613,"journal":{"name":"Neurology-Genetics","volume":"6 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology-Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/nxg.0000000000200106","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

The PMPCA gene encodes the α-subunit of mitochondrial processing peptidase (α-MPP), an enzyme responsible for cleavage of nuclear-encoded mitochondrial precursor proteins after their import into mitochondria. Mutations in this gene have been described in patients with nonprogressive or slow progressive cerebellar ataxia, with variable age at onset and severity. Cerebellar atrophy and striatum changes were found in severe cases.

Methods

The patient was diagnosed using whole exome sequencing. Skin fibroblasts were used for confirmation of α-MPP levels using western blot and mitochondrial morphology assessment of immunofluorescent confocal microscopy images.

Results

Two novel compound heterozygous variants in the PMPCA gene (p.Tyr241Ser and p.Met251Val) were identified in an 8-year-old proband with progressive spastic quadriparesis, delayed psychomotor development, and intellectual disability, with onset at 13 months. The brain imaging showed cortical and cerebellar atrophy, reduced volume of basal ganglia with striatum hyperintensity, and periventricular white matter changes. The patient's fibroblasts showed a decreased α-MPP level and reduced and fragmented mitochondria.

Discussion

The described case contributes to the number of patients with progressive PMPCA-related disease with a severe intermediate phenotype. Moreover, we extend the phenotype to Leigh-like white matter changes that have not been described in previously reported cases.

pmpca相关脑病:新变体,表型扩展和线粒体形态
目的PMPCA基因编码线粒体加工肽酶的α -亚基(α -MPP),该酶在核编码的线粒体前体蛋白进入线粒体后负责切割。该基因突变在非进行性或缓慢进行性小脑性共济失调患者中已被描述,具有不同的发病年龄和严重程度。严重者可出现小脑萎缩和纹状体改变。方法采用全外显子组测序对患者进行诊断。使用免疫荧光共聚焦显微镜图像的western blot和线粒体形态学评估,使用皮肤成纤维细胞来确认& α;-MPP水平。结果在一名8岁的先证患者中发现了两个新的PMPCA基因复合杂合变异(p.t tyr241ser和p.t met251val),该患者患有进行性痉挛性四肢瘫、精神运动发育迟缓和智力残疾,发病时间为13个月。脑显像显示皮质和小脑萎缩,基底节区体积减小,纹状体高,脑室周围白质改变。患者的成纤维细胞显示α -MPP水平下降,线粒体减少和碎片化。该病例增加了严重中间表型进行性pmpca相关疾病患者的数量。此外,我们将表型扩展到以前报道的病例中未描述的leigh样白质变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology-Genetics
Neurology-Genetics Medicine-Neurology (clinical)
CiteScore
6.30
自引率
3.20%
发文量
107
审稿时长
15 weeks
期刊介绍: Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. Original articles in all areas of neurogenetics will be published including rare and common genetic variation, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease-genes, and genetic variations with a putative link to diseases. This will include studies reporting on genetic disease risk and pharmacogenomics. In addition, Neurology: Genetics will publish results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems for treatment trials are welcome, including well-powered studies reporting negative results.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信